As-3 (as-3) - Dosing, PA Forms & Info (2026)
logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. As-3- As-3 solution

    Get your patient on As-3- As-3 solution (As-3)

    Medication interactionsSee all drug-to-drug interactions for this medication.
    card icon
    Prescribing informationPubMed™ news

    As-3- As-3 solution prescribing information

    • Warnings & precautions
    • Description
    • Data source
    • Warnings & precautions
    • Description
    • Data source
    Prescribing Information
    Warnings & Precautions

    Warnings and precoutions section

    See appropriate Operator’s Manual for additional information and complete usage instructions.

    Not for direct intravenous infusion

    Do not use unless solution is clear and no leaks detected

    Single use container. Discard unused portion

    Intended for use only with automated red cell washing and apheresis devices

    Store at room temperature. Avoid excessive heat. Protect from freezing

    Description

    Referenced ImageADDITIVE SOLUTION FORMULA 3 (AS-3), 300 mL

    Each 100 mL contains:
    Citric Acid (Monohydrate), USP 0.042 g
    Monobasic Sodium Phosphate (Monohydrate), USP 0.276 g
    Sodium Chloride, USP 0.410 g
    Adenine, USP 0.030 g
    Dextrose (Anhydrous), USP 1.000 g
    Sodium Citrate (Dihydrate), USP 0.588 g
    containing 15 mEq of Sodium.
    .





    Data SourceWe receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
    Report Adverse Event
    Interactions Banner
    Check medication interactionsReview interactions as part of your prescribing workflow

    As-3- As-3 solution PubMed™ news

      Show the latest PubMed™ articles for As-3- As-3 solution